Skip to main content
. 2021 Oct;9(20):1517. doi: 10.21037/atm-20-8106

Figure 6.

Figure 6

Effects of Berberine on PCSK9, p-ERK and ERK protein expressions in HepG2 cells (A,B). U0126, the ERK1/2 inhibitor, attenuated the decreased PCSK9 expression induced by Berberine in HepG2 cells (C,D). *P<0.05, **P<0.01, ***P<0.001: BBR vs. control; ##P<0.01: BBR + U0126 vs. BBR.